Sounds like the choice between a separate clinical test for a rarer diagnosis, (which generally means more expenses for a smaller market) or just leaving it to doctors to do off label use.
I think you misunderstood my sub-point.. I think we both agree about the BBC as a wonderful result. I question the motives for a special system of protecting it in a government that doesn't seem to get any better at…
Debunking amyloid build up as the cause is different than debunking amyloid build up as any kind of correlation.
Sounds like the choice between a separate clinical test for a rarer diagnosis, (which generally means more expenses for a smaller market) or just leaving it to doctors to do off label use.
I think you misunderstood my sub-point.. I think we both agree about the BBC as a wonderful result. I question the motives for a special system of protecting it in a government that doesn't seem to get any better at…
Debunking amyloid build up as the cause is different than debunking amyloid build up as any kind of correlation.